Updated Data on Gilteritinib in AML

Don Photo

Don
4 years 51 Views
Category:
Description:
Daniel DeAngelo MD, Institute Physician, Professor of Medicine at Harvard Medical School comments on the importance of the updated data on gilteritinib in acute myeloid leukemia (AML).